| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.15 | 7e-06 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.29 | 0.0002 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.57 | 0.0002 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |